Coty Inc. Form 10-Q Summary
Reporting period: Quarter and nine months ended March 31, 2021 (Coty fiscal 2021 third quarter). The request metadata says “2020 Q3,” but the filing itself covers fiscal 2021 Q3. Unless noted, amounts are in U.S. dollars.
Business context and reporting period
Coty sells fragrance, color cosmetics, and skin and body care products globally. Its continuing operations report Americas, EMEA, and Asia Pacific segments. The Professional and Retail Hair business, including Wella, Clairol, OPI, and ghd, was sold as a majority stake to KKR on November 30, 2020; its results are presented as discontinued operations. Coty retained a 40% Wella interest, valued at $1.25 billion at March 31, 2021.
Key financial metrics
| Metric | Three months ended March 31, 2021 | Prior-year quarter | Nine months ended March 31, 2021 | Prior-year period |
|---|---|---|---|---|
| Revenue, continuing operations | $1,027.8 million | $1,062.5 million | $3,567.5 million | $4,157.4 million |
| Gross profit / gross margin | $636.1 million / 61.9% | $601.7 million / 56.6% | $2,126.9 million / 59.6% | $2,502.4 million / 60.2% |
| Operating income (loss), GAAP | $(1.4) million | $(299.5) million | $(50.4) million | $(316.0) million |
| Adjusted operating income, non-GAAP | $95.6 million; 9.3% margin | $(68.2) million; (6.4)% margin | $365.0 million; 10.2% margin | $173.6 million; 4.2% margin |
| Net income (loss), consolidated | $12.7 million | $(264.4) million | $(14.6) million | $(224.5) million |
| Net income (loss) attributable to Coty Inc. | $15.6 million | $(271.6) million | $(15.3) million | $(240.4) million |
| Net loss attributable to common stockholders / diluted EPS | $(18.5) million / $(0.02) | $(271.6) million / $(0.36) | $(93.4) million / $(0.12) | $(240.4) million / $(0.32) |
Quarterly revenue fell 3%; unit volume declined 12%, partly offset by favorable price/mix and foreign exchange. Nine-month revenue fell 14%. Continuing-operation figures exclude Wella for all periods presented. The reported nine-month loss includes discontinued-operation losses, notably the Wella sale loss.
- Cash flow: Nine-month operating cash flow was $286.4 million, versus $204.5 million. Investing cash flow was positive $2,472.1 million, mainly reflecting Wella sale proceeds; financing cash flow was negative $2,742.4 million, primarily from debt repayments.
- Liquidity and debt: Cash and cash equivalents were $315.3 million, with $42.7 million of restricted cash. Management reported $2,376.8 million of immediate liquidity, including available revolver borrowings. Total debt was $5,421.9 million, down from $8,156.3 million at June 30, 2020; net financial debt was $5,106.6 million. Management’s “economic net debt,” net of the retained Wella stake, was approximately $3,856.6 million.
- Interest and capital: Nine-month net interest expense was $171.6 million, down from $185.3 million. Convertible Series B preferred stock carried a 9% annual dividend; accrued preferred dividends reduced income available to common stockholders. Cash dividends on common stock remained suspended.
Material changes versus the prior comparable period
- Quarterly continuing-operation revenue declined modestly, while adjusted operating income improved substantially, primarily due to lower cost of sales, advertising and promotional spending, and administrative and fixed costs. The prior-year quarter included impairment charges and unusually high expenses.
- Quarterly gross margin rose to 61.9%, helped by lower promotional allowances, less inventory obsolescence expense, and manufacturing efficiencies. For the nine-month period, gross margin declined to 59.6%, reflecting product and regional mix and higher minimum royalties, partly offset by lower obsolescence expense.
- Asia Pacific revenue grew 28% in the quarter, while Americas and EMEA revenue declined 6% and 8%. E-commerce and prestige fragrance supported results; lockdowns, weaker color cosmetics demand, and travel retail restrictions weighed on sales.
- The Wella transaction generated initial sale proceeds of $2,451.7 million and a $448.0 million return-of-capital distribution. Coty used $2,015.5 million of net proceeds to repay term loans and reserved $500 million for reinvestment. Nine-month discontinued operations included a $246.6 million loss on sale; the quarter included a further $27.5 million adjustment.
Outlook, management commentary, risks and unusual items
- Management said recovery from COVID-19 would likely be gradual and uneven, with continued pressure from restrictions, reduced travel, and weak color cosmetics demand. It cited emerging improvement in the Americas and Asia, especially prestige fragrance, and continued e-commerce growth. No specific numerical revenue or earnings guidance is provided in the filing text.
- The Transformation Plan targets revenue stabilization and growth, margin improvement, cost control, operating-model changes, digital and e-commerce growth, and deleveraging. Coty reported $340.2 million of cumulative cash costs through March 31, 2021 and approximately $80 million of additional restructuring charges expected over the next three fiscal years for approved actions. Management said it was on track to exit fiscal 2021 with greater cost savings than initially anticipated.
- Unusual income and tax items materially affected reported results: the quarter included a $63.5 million unrealized gain on the Wella investment, contributing to $62.5 million of other income; the nine-month period included a preliminary $220.5 million tax benefit related to the relocation of Coty’s principal location from Geneva to Amsterdam. The tax benefit remains subject to finalization with tax authorities.
- Post-closing Wella working-capital and other purchase-price adjustments could lead to further changes to the sale price and recorded loss; Coty expected resolution by the end of fiscal 2022 Q1. The retained Wella investment is a Level 3 fair-value estimate and depends on significant unobservable valuation assumptions.
- The April 2020 debt-covenant holiday expired April 1, 2021. As of March 31, Coty reported compliance with its debt covenants and immediate liquidity of $2,376.8 million; it also reported a $500 million minimum-liquidity covenant for the period specified in its credit agreement. On April 21, 2021, Coty issued $900 million of 5% senior secured notes due 2026 and used the proceeds to repay term loans and related costs.
- Material risk areas include ongoing COVID-19 effects, execution of the Transformation Plan, leverage and debt-service obligations, foreign-exchange exposure, and dependence on successful product launches and brand licensing. Brazilian tax assessments totaled approximately $281.3 million across disclosed matters; Coty disputed them and had not recorded a loss because management did not consider loss probable. Several stockholder, securities, and trade-secret lawsuits remain pending; the filing says potential losses in certain litigation cannot currently be reasonably estimated.
Important facts for investors to verify
- Whether revenue and consumer demand recover as restrictions ease, particularly in EMEA, mass color cosmetics, and travel retail.
- How much of the improved operating performance reflects durable savings versus reduced advertising, promotion, and discretionary spending.
- Final Wella purchase-price adjustments, the valuation of Coty’s 40% Wella stake, and actual use of the $500 million reinvestment balance.
- Progress on debt reduction, covenant requirements, liquidity, and the impact of the April 2021 refinancing.
- Final resolution of the $220.5 million tax benefit and outcomes of Brazilian tax assessments and pending litigation.
- Potential dilution and preferred-dividend effects from Series B preferred stock, including the CEO’s proposed stock award described in the filing.